Last reviewed · How we verify
NCT05821634
Personalizing Treatment Delivery
NA trial testing Personalized intervention condition: Cognitive behavioral therapy skills in Anxiety Disorders and Symptoms in 81 participants. Currently enrolling.
1 May 2026
Quick facts
| Lead sponsor | Rutgers, The State University of New Jersey |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 81 |
| Start date | 21 October 2024 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 April 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Personalized intervention condition: Cognitive behavioral therapy skills
- Therapeutic control condition: Cognitive behavioral therapy skills
- Tracking control condition: Supportive counseling
Conditions studied
- Anxiety Disorders and Symptoms — all drugs for Anxiety Disorders and Symptoms →
- PTSD and Trauma-related Symptoms — all drugs for PTSD and Trauma-related Symptoms →
- Alcohol; Use, Problem; Alcohol Use Disorder — all drugs for Alcohol; Use, Problem; Alcohol Use Disorder →
Sponsor
Rutgers, The State University of New Jersey
Who can join
Adults 18 to 65, any sex, with Anxiety Disorders and Symptoms or PTSD and Trauma-related Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anxiety and anxiety-related disorders frequently co-occur with alcohol use problems resulting in an enormous humanitarian and economic cost to society. The proposed research will use digital technology to examine person-specific risk factors predicting problematic alcohol use in individuals vulnerable to anxiety and anxiety-related disorders and will use this information to design a personalized intervention for individuals seeking psychological treatment. Results from this research will integrate output from novel and innovative digital technology methods into psychotherapy, advancing research on personalized treatment and prevention efforts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05821634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders and Symptoms
Currently open trials in the same condition.
- NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
- NCT06138730 — Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens · NA · active not recruiting
- NCT06356090 — SPACE: a Parent-based Treatment for Pediatric OCD · NA · recruiting
- NCT05836090 — Family Spirit Strengths · NA · recruiting
- NCT06350760 — Transdiagnostic, Indicated Preventive Intervention for Adolescents At High Risk of Emotional Problems W/Add-On Modules · NA · recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
- NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
- NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
- NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
- NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
- NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05821634 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
- Last refreshed: 29 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05821634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing